[{"Assets_0_Q2_USD":"1724237000.0","CIK":"874716","CommonStockSharesIssued_0_Q2_shares":"105478000.0","CommonStockSharesOutstanding_0_Q2_shares":"86103000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"1.46","EarningsPerShareBasic_2_Q2_USD":"2.65","EarningsPerShareDiluted_1_Q2_USD":"1.43","EarningsPerShareDiluted_2_Q2_USD":"2.61","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"42180715521.0","MinorityInterest_0_Q2_USD":"303000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"171480000.0","NetIncomeLoss_1_Q2_USD":"125706000.0","NetIncomeLoss_2_Q2_USD":"228387000.0","OfficialName":"IDEXX Laboratories Inc. Common Stock","ProfitLoss_1_Q2_USD":"125701000.0","ProfitLoss_2_Q2_USD":"228410000.0","RevenuesConverted_1_Q2_USD":"620103000.0","RevenuesConverted_2_Q2_USD":"1196159000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"171549000.0","StockholdersEquity_0_Q2_USD":"171246000.0","Ticker":"IDXX","TreasuryStockSharesConverted_0_Q2_shares":"19375000.0","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"87615000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"87594000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"86215000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"86210000.0","filed":"20190801","footnote":null,"form":"10-Q","fp":"Q2","fy":"2019.0","name":"IDEXX LABORATORIES INC \/DE","period":"20190630","qtrs":"0","uom":"USD"}]